Blood pressure and hypertension in relation to levels of serum polychlorinated biphenyls in residents of Anniston, Alabama

Journal of Hypertension

Volumn 28, Issue 10, 2010, Pages 2053-2060

  Goncharov, Alexey ^a   Bloom, Michael ^a,b   Pavuk, Marian ^c   Birman, Irina ^a,b   Carpenter, David O ^a,b  

^a UNIVERSITY AT ALBANY   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

age; BMI; diastole; hypertension; lipids; polychlorinated biphenyls; race; systole

Indexed keywords

ANTIHYPERTENSIVE AGENT; LIPID; POLYCHLORINATED BIPHENYL;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXERCISE; FEMALE; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

EID: 77957284770     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833c5f3e     Document Type: Article

References (37)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whealton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:21 7-223.
2. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men. The Framingham heart study. JAMA 2002; 287:10031010.
3. Victor RG. Arterial hypertension. In: Goldman L, Ausiello D, editors. Cecil medicine, 23rd ed. Philadelphia, PA, USA: Saunders; 2008 pp. 430-450.
4. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003; 139:761-776.
5. Kaplan NM, Opie LH. Controversies in cardiology 2: controversies in hypertension. Lancet 2006; 367:168-176.
6. Gus M, Fuchs SC, Moreira LB, Moraes RS, Wiehe M, Silva AF, et al. Association between different measurements of obesity and the incidence of hypertension. Am J Hypertens 2004; 17:50-53.
7. Ferrario CM, Smith R, Levy P, Strawn W. The hypertension-lipid connection: insights into the relation between angiotensin II and cholesterol in atherogenesis. Am J Med Sci 2002; 323:17-24.
8. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005; 365:434-441.
9. Alexander CN, Schneider RH, Staggers F, Sheppard W, Clayborne BM, Rainforth M, et al. Trial of stress reduction for hypertension in older African Americans. Hypertension 1996; 28:228-237.
10. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella E, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000. A rising tide. Hypertension 2004; 44:398-404.
11. Huang X, Lessner L, Carpenter DO. Exposure to persistent pollutants and hypertensive disease. Environ Res 2006; 102:101-106.
12. Kreiss K, Zack MM, Kimbrough RD, Needham LL, Smrek AL, Jones BT. Association of blood pressure and polychlorinated biphenyl levels. JAMA 1981; 245:2505-2509.
13. Everett CJ, Mainous AG, Frithsen IL, Player MS, Matheson EM. Association of polychlorinated biphenyls with hypertension in the 1999-2002 National Health and Nutrition Examination Survey. Environ Res 2008; 108:94-97.
14. Ha MH, Lee DH, Son HK, Park SK, Jacobs DR. Association between serum concentrations of persistent organic pollutants and prevalence of newly diagnosed hypertension: results from the National Health and Nutrition Examination Survey 1999-2002. J Hum Hypertens 2009; 23:274-286.
15. ATSDR (Agency for Toxic Substances and Disease Registry). Health Consultation. Public Comment Release. Evaluation of soil, blood & air data from Anniston, Alabama. Calhoun County, Alabama. EPA Facility ID: ALD004019048. Atlanta, GA 30333; 2000, 51 pp.
16. ATSDR (Agency for Toxic Substances and Disease Registry). Health Consultation. Updated Assessment of PCB Exposures in Anniston, AL. Anniston PCB Site, Anniston, Calhoun County, Alabama. EPA Facility ID: ALD004019048; Atlanta, GA 30333; 2006, 12 pp.
17. Carpenter DO, Morris DL, Legator M. Initial attempts to profile health effects with types of exposures in Anniston, Alabama. Fres Environ Bull 2003; 12:191-195.
18. Pavuk M, Olson JR, Sjodin A, Bonner M, Dearwent SM, Turner WJ, Needham LL, for the Anniston Environmental Health Research Consortium. Assessment of human exposure to PCBs in the Anniston Community Health Survey. Organohalogen Compd 2009; 71:0-137.
19. Hermanson MH, Scholten CA, Compher K. Variable air temperature response of gas-phase atmospheric polychlorinated biphenyls near a former manufacturing facility. Environ Sci Technol 2003; 37:40384042.
20. Hermanson MH, Johnson GW. Polychlorinated biphenyls in tree bark near a former manufacturing plant in Anniston, Alabama. Chemosphere 2007; 68:191-198.
21. Alabama Department of Public Health. Health Consultation. Monsanto Company. Anniston, Calhoun County, Alabama; 1995, 43 pp.
22. Alabama Department of Public Health. Health Consultation. Cobbtown/ Sweet Valley Community PCB Exposure Investigation. Anniston, Calhoun County, Alabama; 1996, 18 pp.
23. ATSDR (Agency for Toxic Substances and Disease Registry). Health Consultation. Exposure Investigation Report. Monsanto Company (a/k/a Solutia Inc./Monsanto). Anniston, Calhoun County, Alabama. EPA Facility ID: ALD004019048. Atlanta, GA 30333; 2000, 22 pp.
24. Sjodin A, Jones RS, Lapeza CR, Focant JF, McGahee EE, Patterson DG. Semiautomated high-throughput extraction and cleanup method for the measurement of polybrominated diphenyl ethers, polybrominated biphenyls, and polychlorinated biphenyls in human serum. Anal Chem 2004; 76:1921-1927. (Pubitemid 38451508)
25. Schisterman EF, Whitcomb BW, Germaine Louis GM, Louis TA. Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect 2005; 113:853-857.
26. Phillips DL, Pirkle JL, Burse VW, Bernert JT Jr, Henderson LO, Needham LL. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 1989; 18:495-500.
27. Bernert JT, Turner WE, Patterson DG Jr, Needham LL. Calculation of serum 'total lipid' concentrations for the adjustment of persistent organohalogen toxicant measurements in human samples. Chemosphere 2007; 68:824831.
28. Patterson DG Jr, Wong LY, Turner We, Caudill SP, Dipietro ES, McClure PC, et al. Levels in the U.S. population of those persistent organic pollutants (2003-2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements. Environ Sci Technol 2009; 43:1211-1218.
29. EPA (US Environmental Protection Agency). National priorities list (NPL). http://www.epa.gov/superfund/sites/npl/index.htm. 2010.
30. IOM (Institute of Medicine of the National Academies). Dioxins and dioxin-like compounds in the food supply: strategies to decrease exposure. Washington, DC: National Academies Press; 2003. p. 318.
31. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, Jacobs DR Jr. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes. Results from the National Health and Examination Survey 1999-2002. Diabetes Care 2006; 29:1638-1644.
32. Codru N, Schymura MJ, Negoita S; Akwesasne Task Force on Environment, Rej R, Carpenter DO. Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans. Environ Health Perspect 2007; 115:1442-1447.
33. Ha M-H, Lee D-H, Jacobs DR. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect 2007; 115:1204-1209.
34. Goncharov A, Haase RF, Santiago-Rivera A, Morse G; Akwesasne Task Force on the Environment, McCaffrey RJ, Rej R, Carpenter DO. High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a Native American population. Environ Res 2008; 106:226-239.
35. Johnson CD, Balagurunathan Y, Tadesse MG, Falahatpisheh MH, Brun M, Walker MK, et al. Unraveling gene-gene interactions regulated by ligandsof the aryl hydrocarbon receptor. Environ Health Perspect 2004; 112:403412.
36. Vezina CM, Walker NJ, Olson JR. Subchronic exposure to TCDD, PeCDF, PCB126 and PCB153: effect on hepatic gene expression. Environ Health Perspect 2004; 112:1636-1644.
37. Zhang J, Yu K. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280:16901691.